Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments.

Megantara S, Rohani R, Zakaria MR, S Biu MT, Kamarulzaman EE, Rusdin A

Open source

DOI
10.2147/dddt.s630179
Published
2026
Container
Drug design, development and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s630179,
  title = {Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments.},
  author = {Megantara S and Rohani R and Zakaria MR and S Biu MT and Kamarulzaman EE and Rusdin A},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s630179},
  url = {https://doi.org/10.2147/dddt.s630179}
}

RIS

TY  - JOUR
TI  - Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments.
AU  - Megantara S
AU  - Rohani R
AU  - Zakaria MR
AU  - S Biu MT
AU  - Kamarulzaman EE
AU  - Rusdin A
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s630179
UR  - https://doi.org/10.2147/dddt.s630179
ER  - 

APA

S, M., R, R., MR, Z., MT, S. B., EE, K., & A, R. (2026). Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments.. Drug design, development and therapy. https://doi.org/10.2147/dddt.s630179

Source records